Q2 2025 13F Holders as of 6/30/2025
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
180M
-
Number of holders
-
88
-
Total 13F shares, excl. options
-
31.6M
-
Shares change
-
-17M
-
Total reported value, excl. options
-
$19.3M
-
Value change
-
-$9.94M
-
Put/Call ratio
-
0.55
-
Number of buys
-
45
-
Number of sells
-
-60
-
Price
-
$0.61
Significant Holders of Tenaya Therapeutics, Inc. - Common Stock, par value $0.0001 per share (TNYA) as of Q2 2025
129 filings reported holding TNYA - Tenaya Therapeutics, Inc. - Common Stock, par value $0.0001 per share as of Q2 2025.
Tenaya Therapeutics, Inc. - Common Stock, par value $0.0001 per share (TNYA) has 88 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 31.6M shares
of 180M outstanding shares and own 17.5% of the company stock.
Largest 10 shareholders include Column Group LLC (9.4M shares), VANGUARD GROUP INC (4.76M shares), BlackRock, Inc. (2.73M shares), RENAISSANCE TECHNOLOGIES LLC (1.84M shares), AQR CAPITAL MANAGEMENT LLC (1.74M shares), GEODE CAPITAL MANAGEMENT, LLC (1.23M shares), Euclidean Capital LLC (1.02M shares), Alphabet Inc. (916K shares), MILLENNIUM MANAGEMENT LLC (681K shares), and Aberdeen Group plc (601K shares).
This table shows the top 88 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.